FACIT is a business accelerator and investor established by the Ontario Institute for Cancer Research (OICR) to support the commercialization of Ontario breakthrough cancer innovations that benefit patients, researchers, investors and the province's economy.
Location: Canada, Ontario, Toronto
Employees: 1-10
Founded date: 2014
Investment Type: Accelerator
Investment Stage: Series A
Portfolio 32
| Date | Name | Website | Total Raised | Location |
| 26.04.2023 | cTRL Thera... | ctrl-thera... | $10M | Canada, On... |
| 23.02.2017 | Fusion Pha... | fusionphar... | $195.91M | Canada, On... |
| - | health.sun... | - | - | |
| - | Harmonic M... | harmonicme... | - | - |
| - | 404 Page | dbms.queen... | - | - |
| - | Nanology L... | nanologyla... | - | Canada, On... |
| - | Radialis M... | rezniklab.... | - | - |
| - | Privacy An... | privacy-an... | $3.5M | Canada, On... |
| - | KA Imaging... | kaimaging.... | - | Canada, On... |
| - | Faculty: R... | pharmtox.u... | - | - |
Show more
Mentions in press and media 8
| Date | Title | Description | Source |
| 02.07.2019 | Startup competitions seeking companies focused on cancer | They include Freedom from Cancer Startup Challenge and FACIT's Annual Pitch Competition If you're a... | vator.tv/n... |
| 09.04.2019 | Nanology Labs receives investment from oncology research fun... | Nanology Labs, a pharmaceutical startup based out of the University of Toronto, has received an inve... | betakit.co... |
| 22.03.2017 | Propellon Therapeutics Raises $3.0M in Seed Financing | Propellon Therapeutics, a Toronto, Canada-based developer of a portfolio of WDR5-targeted anti-cance... | finsmes.co... |
| 22.03.2017 | Facit Launches The Prospects Oncology Fund | Toronto, Ontario, Canada-based Fight Against Cancer Innovation Trust (“FACIT”) has launched The Pros... | finsmes.co... |
| 29.10.2015 | Today in funding ($51M): Turnstone Biologics, Invixium, Qvel... | This week, three Toronto-based companies raised impressive Series A rounds – two of them in healthte... | betakit.co... |
| 28.10.2015 | Turnstone Biologics Completes $11.3M Series A Financing Roun... | Turnstone Biologics Inc., a Toronto, Ontario, Canada-based developer of novel oncolytic viral immuno... | finsmes.co... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed... | Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-parti... | healthcap.... |
| - | Fusion Pharmaceuticals Launches with a $25M USD Series A Fin... | HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical compa... | healthcap.... |